As of 2025-05-15, the Net Margin of Oramed Pharmaceuticals Inc (ORMP) is 412.3%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | 412.3% |
2023-12-31 | 412.3% |
2022-12-31 | -1354.1% |
2021-12-31 | -1290.7% |
2021-08-31 | -823.7% |
2020-08-31 | -424.7% |
2019-08-31 | -531.8% |
2018-08-31 | -519.6% |
2017-08-31 | -426% |
2016-08-31 | -1712.5% |